Target intelligence / Profile preview

Invertebrate glutamate-gated chloride channel (GluCl) (GluCl)

Target
GluCl
Molecular classification
Ion channel, Cys-loop ligand-gated ion channel, Receptor
01

Overview

Invertebrate glutamate-gated chloride channels (GluCls) are members of the Cys-loop family of ligand-gated ion channels that mediate fast inhibitory neurotransmission in protostome invertebrates, such as nematodes and arthropods (Wolstenholme, 2012). These channels are activated by the neurotransmitter L-glutamate, leading to an influx of chloride ions that hyperpolarizes the cell membrane and inhibits electrical activity (Hibbs & Gouaux, 2011). A defining feature of GluCls is their absence in vertebrate genomes, which makes them an ideal target for highly selective antiparasitic and insecticidal agents (Cully et al., 1994). The most prominent drugs targeting these channels are the macrocyclic lactones, including ivermectin, which act as potent positive allosteric modulators that stabilize the open state of the channel (Lynagh & Lynch, 2012). This action results in the flaccid paralysis of the parasite's somatic muscles and pharynx, preventing movement and feeding, and eventually leading to the death of the organism (Wolstenholme, 2012). In clinical practice, these channels are central to the treatment of human diseases like onchocerciasis and various veterinary parasitic infections, though their utility is increasingly threatened by the emergence of drug resistance (Menez et al., 2012).

Other names
Glutamate-gated chloride channelGluCl receptorAvermectin-sensitive glutamate-gated chloride channelGluClRH-receptor
02

Mechanism of action

Positive allosteric modulation and agonism of the channel, leading to increased chloride ion permeability, hyperpolarization of neurons and muscle cells, and subsequent flaccid paralysis (Wolstenholme, 2012).

03

Biological functions

Inhibitory neurotransmissionLocomotionFeeding behaviorSensory processing
04

Disease associations

InfectionHelminthiasisEctoparasitic infestationAgricultural pest control
05

Safety considerations

Neurotoxicity in MDR1-deficient hostsDevelopment of anthelmintic resistanceOff-target effects on vertebrate GABA receptors
06

Interacting drugs

Ivermectin

10 more in the full profile.

07

Biomarkers

ABCB1 (MDR1) genotypeParasite motilityFecal egg count reduction

Beyond the preview

Go deeper on Invertebrate glutamate-gated chloride channel (GluCl) (GluCl).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invertebrate glutamate-gated chloride channel (GluCl) (GluCl).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call